v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Operating activities      
Net Income (Loss) $ (246,860) $ (123,196) $ (140,509)
Adjustments to reconcile net loss to net cash used in operating activities      
Depreciation and amortization 41,825 45,637 47,639
Stock-based compensation, net of capitalized cost of $2,605, $2,339 and $2,344, respectively 54,995 48,485 57,132
Change in fair value of warrant liabilities 161,400 15,116 (13,709)
Change in fair value of contingent consideration 465 3,437 (741)
Other 1,225 (920) (4,321)
Changes in operating assets and liabilities      
Accounts receivable (30,225) (11,984) (2,658)
Inventories (609) 0 0
Prepaid expenses and other assets (11,138) 8,366 10,498
Accounts payable, accrued and other liabilities 13,800 (13,337) (25,014)
Deferred revenue 151,054 15,572 22,237
Deferred hosting costs (1,570) (1,550) (1,265)
Net cash provided by (used in) operating activities 134,362 (14,374) (50,711)
Investing activities      
Purchases of property and equipment (76,714) (44,297) (37,991)
Capitalized internal-use software (4,783) (5,322) (4,419)
Maturities of available-for-sale securities 90,009 61,396 161,317
Sales of available-for-sale securities 33,229 192,522 45,580
Purchases of available-for-sale securities (428,008) (140,240) (189,142)
Business acquisition, net of cash acquired (5,400) (1,068) (7,542)
Purchases of licensed imagery intangible assets (1,451) (4,785) 0
Other 0 (300) (1,389)
Net cash provided by (used in) investing activities (393,118) 57,906 (33,586)
Financing activities      
Proceeds from the exercise of common stock options 27,708 4,375 7,388
Payments for withholding taxes related to the net share settlement of equity awards (72,729) (11,938) (8,971)
Proceeds from employee stock purchase program 2,802 1,549 0
Payments of contingent consideration for business acquisitions (4,047) (8,783) 0
Payment of indemnification holdback for business acquisition (5,000) 0 0
Proceeds from issuance of convertible notes, net of discount 448,759 0 0
Payment of debt issuance costs (2,929) 0 0
Proceeds from the exercise of warrants 4,845 0 0
Purchase of capped call transactions (39,560) 0 0
Other (2,797) (738) (15)
Net cash provided by (used in) financing activities 357,052 (15,535) (1,598)
Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents 7,264 (201) 17
Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalent 105,560 27,796 (85,878)
Cash and cash equivalents, and restricted cash and cash equivalents at the beginning of the period 129,994 102,198 188,076
Cash and cash equivalents, and restricted cash and cash equivalents at the end of the period 235,554 129,994 102,198
Supplemental disclosures of noncash investing and financing activities      
Contingent consideration for business acquisition 0 0 5,842
Issuance of Class A common stock for business acquisition 0 0 21,622
Transfers from property and equipment, net to inventories, net 5,523 0 0
Accrued purchase of property and equipment $ 5,019 $ 718 $ 1,428